Antibiotic Resistance Market Analysis
The antibiotic resistance market is likely touch USD 13,146 million at a 5.8% CAGR between 2019- 2025, as per the new Market Research Future’s antibiotic resistance statistics. Antibiotics are medicines that are used for preventing and treating bacterial infections. Antibiotic resistance takes place when the bacteria changes in response to the usage of such medicines. The bacteria become antibiotic-resistant and not humans. These bacteria then may infect humans and are difficult to treat in comparison to non-resistant bacteria. Along with antibiotic resistance, antimicrobial resistance too may take place. Antimicrobial drug resistance encompasses resistance to drugs for treating infections resulting from other microbes such as fungi, viruses, and parasites.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8579
Numerous factors are adding to the antibiotic resistance market demand. Such factors, as revealed by the latest MRFR report, include increasing initiatives worldwide to control drug-resistance, rise in clinical developments of antibiotic resistance, increasing prevalence of infectious & chronic disease, and growing antibiotic drug resistance infections.
On the contrary, the high medical cost may limit the antibiotic resistance industry growth over the forecast period.
Antibiotic Resistance Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the antibiotic resistance market based on end user, pathogen, disease, and drug class.
By drug class, the antibiotic resistance market is segmented into oxazolidinones, lipoglycopeptides, tetracyclines, combination therapies, cephalosporins, and others. Others have again been segmented into vancomycin, sulfonamide, and others. Of these, combination therapies will lead the market over the forecast period for the rising use of such therapies for gram-negative infections, which have limited treatment.
By disease, the antibiotic resistance market is segmented into community-acquired bacterial pneumonia, hospital-acquired bacterial pneumonia/ventilator, acute bacterial skim & skin structure infections, clostridium difficile infections, complicated intra-abdominal infections, bloodstream infections, and complicated urinary tract infection. Of these, complicated urinary tract infections will dominate the market over the forecast period.
By pathogen, the antibiotic resistance market is segmented into campylobacter, pneumonia, clostridium difficile, pseudomonas aeruginosa, hemophilus influenza, enterococcus, acinetobacter, streptococcus pneumonia, staphylococcus aureus, and others. Others are again segmented into enterobacteriaceae, Neisseria gonorrhoeae, salmonella, and others. Of these, pneumonia will have the largest share in the market over the forecast period.
By end use, the antibiotic resistance market is segmented into research organizations, hospitals and clinics, and others. Others are again segmented into emergency care centers, nursing homes, and academic institutes. Of these, hospitals and clinics is predicted to have a major share in the market over the forecast period for the majority of the procedures and treatments being carried out in hospitals.
Antibiotic Resistance Market Regional Analysis
By region, the global antibiotic resistance market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. Factors propelling the antibiotic resistance market growth in the region include rising incidence of infectious diseases, rising adoption of antibiotic resistance, and rapidly growing pharmaceutical sector.
The global antibiotic resistance market in Europe is predicted to hold the second-largest share during the forecast period for an increase in bacterial infections, rising incidence of infectious diseases, and increasing consumption of antibiotic resistance.
The global antibiotic resistance market in the APAC region is predicted to grow at a high CAGR over the forecast period for the increasing number of hospital-acquired infections and antibiotic-resistant infections.
The global antibiotic resistance market in the MEA is predicted to have healthy growth over the forecast period for the increasing consumption of antibiotic resistance and rising healthcare expenditure.
Antibiotic Resistance Market Key Players
Eminent players profiled in the global antibiotic resistance market report include Allecra Therapeutics (US), Procarta Biosystems (England), NEMESIS BIOSCIENCE LTD (UK), Entasis Therapeutics (US), Basilea Pharmaceutica Ltd. (Switzerland), Tetraphase Pharmaceuticals (US), Theravance Biopharma (UK), Seres Therapeutics (US), PARATEK Therapeutics (US), Nabriva Therapeutics plc (Ireland), MELINTA THERAPEUTICS, INC. (US), and Achaogen, Inc. (US). Industry players have incorporated strategies such as extensive research and development activities, strategic alliances, partnerships, acquisitions, mergers, new product development and launches, and collaborations to stay ahead in the competition.
Browse In-depth Market Research Report (199 pages) on Antibiotic Resistance Market @ https://www.marketresearchfuture.com/reports/antibiotic-resistance-market-8579
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
Market HighlightsAccording to MRFR analysis, Antibiotic Resistance Market is expected to register a CAGR of 5.8% during the forecast period of 2019 to 2025 and was valued at USD 8,120 Million in 2018.Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs.
Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8579The growth of global antibiotic resistance market is driven by various factors such as - Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance Several market players currently dominate the global antibiotic resistance market.
The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector.
The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others.
Antibiotic Resistance Market: Information by Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies and others), Disease (Complicated Urinary Tract Infection (cUTI), Blood Stream Infections (BDS), Complicated Intra-Abdominal Infections (cIAI), Clostridium Difficile Infections (CDI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital-Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community-Acquired Bacterial Pneumonia (CABP), Others), Pathogen (Staphylococcus Aureus , Streptococcus pneumonia, Acinetobacter, Enterococcus Faecium, Hemophilus Influenzae, Pseudomonas Aeruginosa, Clostridium Difficile, K. Pneumoniae, Others), End-User (Hospitals and Clinics, Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Antibiotic Resistance Market-OverviewThe popularity and effectiveness of antibiotics have risen exponentially since their mainstream introduction.
The pharmaceutical reports are made by Market Research Future, which includes market options for expansion.
A USD 13,146 Million is estimated to be accumulated by the market by 2025 while progressing at a CAGR of 5.8%.The natural occurrence of resistance to antibiotics to their intensive or prolonged use is estimated to create an augmented scope for the antibiotic resistance market growth.
Based on disease, the antibiotic resistance market has been segmented into hospital-acquired bacterial pneumonia/ventilator, complicated urinary tract infections, complicated intra-abdominal infections, bloodstream infections, community-acquired bacterial pneumonia, acute bacterial and skin structure infections, clostridium difficile infections, and others.
On the basis of pathogen, the antibiotic resistance market is segmented into streptococcus pneumoniae, k. pneumoniae, acinetobacter, staphylococcus aureus, enterococcus, pseudomonas aeruginosa, clostridium difficile, hemophilus influenzae, campylobacter, and others.Detailed Regional Analysis The regional examination of the antibiotic resistance market is conducted for regions such as Americas, Asia-Pacific the Middle East, Europe and Africa.
The intensifying growth in the pharmaceutical sector, intensifying approval of antibiotic resistance, mounting prevalence of communicable diseases are the noteworthy factors that would propel the development of the antibiotic resistance market in this region.
Antibiotic Resistance Market Antibiotics are the medications that are widely used for the treatment of various types of infections.
Antibiotics resistance develops when infections stop responding to the existing antibiotics.
It becomes major health and economic challenges of global public health concern.
It is potentially threaten to the effective treatment of the infectious infections.According to the statistics published by Johnson & Johnson Services, Inc, antibiotics resistance was responsible for over 700,000 deaths every year worldwide including more than 50,000 in the U.S and the Europe.
Increases of cases of prevalence rate, Advances in antibiotics and immunization and accelerate demanding of novel therapies are the drivers for market growth.Market DriversIncreases of cases of prevalence rate of infectious diseases worldwide is act as drivers for market growthAdvances in nutrition, antibiotics and immunization is accelerating the market growthAccelerate demanding of novel therapies is enhancing the market growthPrevalence of indoor as well as outdoor infections is propelling the market growthMarket RestraintsEffective treatment is either unavailable or unaffordable is restraining the market growthPatent expiry from many companies and introduction of generic drugs is expected to restrain the growth of the market.Lack of trained personnel and stringent safety regulations is hampering the market growthGet Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antibiotic-resistance-marketSome of the leading key players profiled in this study:Few of the major competitors currently working in the global antibiotic resistance market are Achaogen, Inc, Nabriva Therapeutics plc, BioVersys AG, Johnson & Johnson Services, Inc, Destiny Pharma plc, Armata Pharmaceuticals, Inc, Westway Health, NEMESIS BIOSCIENCE LTD, Tetraphase Pharmaceuticals, The Medicines Company, ALLERGAN, Merck & Co., Inc., Pfizer Inc, CARB-X, MELINTA THERAPEUTICS, INC, , Novartis AG, Vertex Pharmaceuticals Incorporated, GlaxoSmithKline Plc, AbbVie Inc, F. Hoffmann-La Roche Ltd and others.
Antibiotic Resistance Market Similar Report Here:Brain Aneurysm MarketTransdermal Drugs MarketKey Pointers Covered in the Antibiotic Resistance Market Trends and Forecast to 2026 Antibiotic Resistance Market New Sales Volumes Antibiotic Resistance Market Replacement Sales Volumes Antibiotic Resistance Market Installed Base Antibiotic Resistance Market By Brands Antibiotic Resistance Market Size Antibiotic Resistance Market Procedure Volumes Antibiotic Resistance Market Product Price Analysis Antibiotic Resistance Market Healthcare Outcomes Antibiotic Resistance Market Cost of Care Analysis Antibiotic Resistance Market Regulatory Framework and Changes Antibiotic Resistance Market Prices and Reimbursement Analysis Antibiotic Resistance Market Shares in Different RegionsRecent Developments for Antibiotic Resistance Market Competitors Antibiotic Resistance Market Upcoming Applications Antibiotic Resistance Market Innovators Study Get Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=global-antibiotic-resistance-marketScope of the Antibiotic Resistance MarketCurrent and future of Antibiotic Resistance Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Antibiotic Resistance Market By Disease Type (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections and Others), Pathogen Type (Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, Streptococcus Pneumoniae and Others) Drugs Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026Inquiry before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-antibiotic-resistance-marketAbout Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
